At this time, posts about Medytox are rapidly increasing on portals and securities communities. Today, foreigners have sold a net 3,000 shares of Medytox, and institutions have sold a net 11,000 shares, according to provisional data. Medytox is known as a manufacturer and seller of pharmaceuticals and cosmetic pharmaceuticals.

As of 11:30 AM on the 18th, Medytox's stock price is 124,600 KRW, down 16.93% from the previous day, with a trading volume of 1,046,531 shares, which is 316.31% of the 5-day average trading volume. On June 10, Medytox was a market issue due to the "shipment approval news of Meditoxin 200 units," which caused an upward trend.

In addition to Medytox, posts by investors are also rapidly increasing regarding Firstec (010820), Optipharm (153710), and SK Securities Preferred (001515).

※Source: AI Investment Assistant AI Racciro

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing